Elevated levels of the MPO-oxidized apoA1 form, oxTrp72-apoA1, in subjects are thus associated with increased cardiovascular disease risk, and may serve for monitoring a pro-atherogenic process in the artery wall. This evidence concerns the gene APOA1 and cardiovascular disorder.